Registration open for VRIC

Dec 31, 2019 Re-posted from the January 2020 issue of Vascular Specialist

Register today for the 2020 Vascular Research Initiatives Conference, to be held Monday, May 4, in Chicago.

The conference emphasizes emerging vascular science and encourages interactive participation of all attendees. VRIC Chicago 2020: “From Discovery to Translation” takes place at the Hilton Chicago Hotel, the same venue for the American Heart Association’s Vascular Discovery Scientific Sessions (May 5‒7).

The VRIC program includes four abstract sessions, a translational panel, poster presentations and the Alexander W. Clowes Distinguished Lecture, presented this year by Philip S. Tsao, PhD, of Stanford University School of Medicine and the Veterans Administration Palo Alto Epidemiology Research and Information Center for Genomics. His talk is entitled “Molecular mechanisms of AAA disease.”

Registration is $275 for members, $300 for nonmembers and $150 for residents, students and candidates. Learn more and access the registration link at vsweb.org/VRIC19.

Tags
Vascular Specialist

Related Articles

Education and Representation at the Core of Inclusivity Efforts for DEI Committe

This article was published in the October issue of Vascular Specialist.

The Society for Vascular Surgery’s (SVS) Diversity, Equity, and Inclusion (DEI) Committee continues to make strides in advancing inclusivity within the organization, with several projects underway to address both ongoing challenges and new opportunities.

Why donate to the SVS PAC?

A few years ago, in his presidential address to the Midwestern Vascular Surgical Society, Mark Mattos, MD, spoke eloquently about the need to “protect our specialty.” A large part of this, he argued, is protecting our patients; no other specialty in medicine can provide the type of comprehensive vascular care that we offer. The daily reality we all face is the potential for declining Medicare reimbursement for our services.

Progress made during year like no other

While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.